Analysts lowered Albemarle Corporation's 12-month price target to $132.75 while maintaining a Buy consensus. The adjustment reflects a 51% upside potential based on the November 17 closing price.
RBC lowered Albemarle's price target to USD 129.00 while maintaining an Outperform rating after Q2 revenue rose 31%. Investors anticipate Q3 results on November 4, 2026, as a key valuation factor.
POSCO and Anson Resources finalized a binding agreement for a direct lithium extraction demonstration plant at Utah's Green River project, aiming for commercial operations by 2027. POSCO will fund the
BMO Capital Markets reduced its price target for Lithium Argentina (LAAC) to USD 8 from USD 9, highlighting Q3 2026 results as a key catalyst for the lithium extraction firm.
Argus Research raised its target price for Balchem Corporation (BCPC) to $167.00, highlighting the company's specialty performance ingredients business, while current trading stands at $168.63.